Inceptive
Foundation models of life, for life.
Palo Alto, United States · Founded 2021 · $120.0M raised
- Headquarters
- Palo Alto, California
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- inceptive.life
- Total Funding
- $120.0M
- Last Round
- $100.0M Series ASep 2023
- Rounds
- 2
About
Inceptive builds foundation AI models for biological drug discovery, training end-to-end on heterogeneous multi-scale data spanning sequence, structure, and function. The company partners with leading pharmaceutical firms to co-design novel RNA-based drug candidates that outperform existing molecules. Founded in 2021 by AI and biochemistry pioneers, Inceptive has offices in Palo Alto, Berlin, and Zurich.
Summary
Inceptive is an Artificial Intelligence company based in Palo Alto, United States, founded in 2021. It has raised $120.0M in total across 2 rounds, most recently a $100.0M Series A round in Sep 2023. Investors include Obvious Ventures, Nvidia NVentures and Andreessen Horowitz.
Tech & App Stack
6 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2023
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.

Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Global contract research organization providing comprehensive drug development and laboratory ser...

